Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Preston

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
Cancer Chemotherapy and Pharmacology|September 17, 2008
Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumorsChia-Chi Lin, Emiliano Calvo, Kyriakos P Papadopoulos, et al.
Familial Cancer|June 15, 2023
A mosaic pathogenic variant in MSH6 causes MSH6-deficient colorectal and endometrial cancer in a patient classified as suspected Lynch syndrome: a case reportRomy Walker, Mark Clendenning, Jihoon E Joo, et al.
Journal of Medicinal Chemistry|July 14, 2021
Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) InhibitorsSimon C C Lucas, Stephen J Atkinson, Chun-Wa Chung, et al.
Familial Cancer|January 31, 2026
Germline MLH1 c.-42 C > T is a likely pathogenic variant predisposing to a reduced-penetrance/modified Lynch syndrome phenotype featuring MLH1-methylated cancersDaniel D Buchanan, Rocio Alvarez, Khalid Mahmood, et al.
Cancers|June 2, 2021
DNA Methylation Signatures and the Contribution of Age-Associated Methylomic Drift to Carcinogenesis in Early-Onset Colorectal CancerJihoon E Joo, Mark Clendenning, Ee Ming Wong, et al.
Plos Neglected Tropical Diseases|August 28, 2020
Epidemiological insights from a large-scale investigation of intestinal helminths in Medieval EuropePatrik G Flammer, Hannah Ryan, Stephen G Preston, et al.
Ebiomedicine|March 30, 2025
Intratumoural pks<sup>+</sup>Escherichia coli is associated with risk of metachronous colorectal cancer and adenoma development in people with Lynch syndromeYen Lin Chu, Peter Georgeson, Mark Clendenning, et al.
Cell Genomics|April 9, 2026
ClinGen API platform for classification of human genetic variantsNeethu Shah, Tierra Farris, Arturo Alejandro Zuniga, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|October 31, 2008
Increased recognition of Powassan encephalitis in the United States, 1999-2005Steven R Hinten, Geoffrey A Beckett, Kathleen F Gensheimer, et al.
British Journal of Cancer|January 10, 2024
Intratumoral presence of the genotoxic gut bacteria pks<sup>+</sup> E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancerJihoon E Joo, Yen Lin Chu, Peter Georgeson, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
Cancer Chemotherapy and Pharmacology|September 17, 2008
Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumorsChia-Chi Lin, Emiliano Calvo, Kyriakos P Papadopoulos, et al.
Familial Cancer|June 15, 2023
A mosaic pathogenic variant in MSH6 causes MSH6-deficient colorectal and endometrial cancer in a patient classified as suspected Lynch syndrome: a case reportRomy Walker, Mark Clendenning, Jihoon E Joo, et al.
Journal of Medicinal Chemistry|July 14, 2021
Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) InhibitorsSimon C C Lucas, Stephen J Atkinson, Chun-Wa Chung, et al.
Familial Cancer|January 31, 2026
Germline MLH1 c.-42 C > T is a likely pathogenic variant predisposing to a reduced-penetrance/modified Lynch syndrome phenotype featuring MLH1-methylated cancersDaniel D Buchanan, Rocio Alvarez, Khalid Mahmood, et al.
Cancers|June 2, 2021
DNA Methylation Signatures and the Contribution of Age-Associated Methylomic Drift to Carcinogenesis in Early-Onset Colorectal CancerJihoon E Joo, Mark Clendenning, Ee Ming Wong, et al.
Plos Neglected Tropical Diseases|August 28, 2020
Epidemiological insights from a large-scale investigation of intestinal helminths in Medieval EuropePatrik G Flammer, Hannah Ryan, Stephen G Preston, et al.
Ebiomedicine|March 30, 2025
Intratumoural pks<sup>+</sup>Escherichia coli is associated with risk of metachronous colorectal cancer and adenoma development in people with Lynch syndromeYen Lin Chu, Peter Georgeson, Mark Clendenning, et al.
Cell Genomics|April 9, 2026
ClinGen API platform for classification of human genetic variantsNeethu Shah, Tierra Farris, Arturo Alejandro Zuniga, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|October 31, 2008
Increased recognition of Powassan encephalitis in the United States, 1999-2005Steven R Hinten, Geoffrey A Beckett, Kathleen F Gensheimer, et al.
British Journal of Cancer|January 10, 2024
Intratumoral presence of the genotoxic gut bacteria pks<sup>+</sup> E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancerJihoon E Joo, Yen Lin Chu, Peter Georgeson, et al.
Pageof 16